Donoghue Forlines LLC Makes New $354,000 Investment in National Health Investors, Inc. (NYSE:NHI)

Donoghue Forlines LLC bought a new stake in National Health Investors, Inc. (NYSE:NHI) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,632 shares of the real estate investment trust’s stock, valued at approximately $354,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Janney Montgomery Scott LLC grew its holdings in National Health Investors by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 23,707 shares of the real estate investment trust’s stock valued at $1,324,000 after purchasing an additional 200 shares during the last quarter. Sound Income Strategies LLC grew its stake in shares of National Health Investors by 33.5% during the fourth quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock valued at $51,000 after buying an additional 230 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of National Health Investors by 6.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock worth $222,000 after buying an additional 238 shares during the period. Atria Wealth Solutions Inc. lifted its stake in shares of National Health Investors by 4.6% during the 4th quarter. Atria Wealth Solutions Inc. now owns 8,200 shares of the real estate investment trust’s stock worth $458,000 after acquiring an additional 359 shares during the last quarter. Finally, Compass Wealth Management LLC purchased a new position in National Health Investors during the 1st quarter valued at $30,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. acquired 437 shares of the business’s stock in a transaction dated Friday, May 31st. The shares were purchased at an average price of $65.83 per share, with a total value of $28,767.71. Following the transaction, the director now directly owns 21,585 shares in the company, valued at $1,420,940.55. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 7.26% of the company’s stock.

National Health Investors Stock Up 2.0 %

NYSE NHI traded up $1.43 during midday trading on Tuesday, hitting $73.59. 45,500 shares of the company traded hands, compared to its average volume of 161,736. The company has a debt-to-equity ratio of 0.91, a current ratio of 13.24 and a quick ratio of 13.24. The company has a market cap of $3.20 billion, a PE ratio of 23.66 and a beta of 1.02. National Health Investors, Inc. has a 52 week low of $48.51 and a 52 week high of $73.66. The company’s 50-day simple moving average is $66.90 and its 200-day simple moving average is $61.02.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be issued a $0.90 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a yield of 4.89%. National Health Investors’s dividend payout ratio is presently 118.03%.

Analysts Set New Price Targets

Several research firms have recently weighed in on NHI. Truist Financial lifted their target price on National Health Investors from $58.00 to $65.00 and gave the stock a “hold” rating in a research report on Wednesday, June 26th. StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Wells Fargo & Company increased their price objective on National Health Investors from $63.00 to $69.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Finally, Wedbush lifted their target price on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $62.13.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.